Effect of Decreasing Trioxypurine Therapy on Patients with Hypertension and Asymptomatic Hyperuricemia

Yuanfang Ma,Weihua Li,Qiang Xie,Lin Kang,Guo Yong-jun,Jing Han
2012-01-01
Journal of Clinical Cardiology
Abstract:Objective:To investigate the effect of decreasing trioxypurine therapy on blood pressure and blood pressure variability(BPV) in patients with hypertension and asymptomatic hyperuricemia.Method : One hundred and forty patients with hypertension and asymptomatic hyperuricemia were randomly divided into test group(n = 70) and control group(n = 70).Patients in test group underwent routine antihypertensive treatment in addition to decreasing trioxypurine therapy,while patients in control group underwent antihypertensive treatment only.At the end of eight weeks,serum uric acid levels were compared before and after treatment,and 24 h ambulatory blood pressure monitoring was adopted for average blood pressure and BPV.Result: ①Compared with before treatment,serum uric acid levels were significantly decreased in test group(P 0.05),and there was no difference in control group(P 0.05).The average blood pressure(24 h SBP,24 h DBP,dSBP,dDBP,nSBP,nDBP) and the BPV(24 h SBPSD,24 h DBPSD,dSBPSD,dDBPSD,nSBPSD,nDBPSD) were significantly decreased in both groups(all P 0.05).②Compared with control group after treatment,the serum uric acid levels of test group were significantly decreased [(350.5 ± 42.3) μmol / L vs(478.6 ± 37.1) μmol / L,P 0.05].And the parameters of 24 h SBPSD,dSBPSD,nSBPSD in test group were significantly decreased [(10.8 ± 1.5) vs(13.2 ± 1.6),(7.9 ± 1.3) vs(10.9 ± 1.3),(6.7 ± 1.2) vs(9.2 ± 1.7),all P 0.05].Conclusion: Routine anti-hypertension therapy integrated with decreasing trioxypurine therapy can improve BPV in patients with hypertension and asymptomatic hyperuricemia,which may produce a beneficial effect on the prognosis of patients with hypertension and asymptomatic hyperuricemia.
What problem does this paper attempt to address?